Institution scientifique

OHSU Knight Cancer Institute

Portland · healthcare

1002Publications signalées

53799Citations signalées

12Thèmes principaux

Principaux domaines

Cancer Genomics and DiagnosticsGastrointestinal Tumor Research and TreatmentProstate Cancer Treatment and ResearchChronic Myeloid Leukemia TreatmentsCancer Immunotherapy and BiomarkersAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchSingle-cell and spatial transcriptomicsGastric Cancer Management and OutcomesCAR-T cell therapy researchSarcoma Diagnosis and TreatmentLung Cancer Treatments and Mutations

Évolution annuelle

19792

19812

19963

19974

19983

19995

20007

20015

20025

20064

20078

20085

200911

201024

201116

201216

201337

201428

201525

201639

201741

201852

201951

202074

202168

202249

202398

202479

202554

202643

Publications récentes

2026 article

ORAL ABSTRACT: CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 article

POSTER: CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

2026 conference-abstract

CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML

Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 article

OPTI-AML: Prospective Comparison of 28 vs.14 days of Venetoclax Induction with Azacitidine in Older Adults with AML

Uma Borate, Ying Huang, Tara L. Lin, Shivani Handa et autres

1 citationBlood

Accès ouvert 2026 article

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Jörge E. Cortes, D Réa, Michael J. Mauro, Andreas Hochhaus et autres

0 citationsLeukemia

Accès ouvert 2026 article

Infection Burden in Mismatched Unrelated Donor Hematopoietic Cell Transplantation: Results from the ACCESS Trial

Jeffery J. Auletta, Joseph Stanek, Stephanie Bo-Subait, Monzr M. Al Malki et autres

0 citationsBlood Advances

Accès ouvert 2026 article

Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis

Kitsada Wudhikarn, Maria Bromberg, Jamie Brower, Venkatraman Seshan et autres

0 citationsBlood Advances

Accès ouvert 2026 article

International End-of-Life Choices

Charles D. Blanke, Benjamin W. Corn, Henry Ddungu, Julie R. Gralow et autres

0 citationsAmerican Society of Clinical Oncology Educational Book

2026 conference-abstract

Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.

Mark Agulnik, Jason K. Sicklick, S. Patel, Mrinal M. Gounder et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 conference-abstract

DART (NCI/SWOG S1609): Comprehensive results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.

Sandip Pravin Patel, Megan Othus, Young Kwang Chae, Tali Azenkot et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstract

RALLY-MF: Initial efficacy of a phase 2 study of DISC-0974, an anti-hemojuvelin antibody, to treat anemia in myelofibrosis.

Naseema Gangat, Ayalew Tefferi, Prithviraj Bose, Elizabeth O. Hexner et autres

1 citationJournal of Clinical Oncology

2026 conference-abstract

Cross-modality AI modeling of histopathology images to stratify outcomes among patients treated with hormonal or chemo-hormonal therapy in ER+/HER2− breast cancer.

Hassan Muhammad, Shweta S. Chavan, Chao Feng, Dianna K. Almaraz et autres

0 citationsJournal of Clinical Oncology

Site officiel Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.